首页|基于网络药理学和分子对接技术初探红柳治疗酒精性肝损伤的作用机制及实验验证

基于网络药理学和分子对接技术初探红柳治疗酒精性肝损伤的作用机制及实验验证

扫码查看
目的 基于网络药理学和分子对接技术,研究天然植物红柳治疗小鼠酒精性肝损伤(ALI)的作用机制.方法 使用TCMSP平台,以口服利用度≥30%和类药性≥0.18分别作为预设条件,对红柳活性化学成分进行筛选;使用GeneCards、DrugBank等数据库,筛选ALI相关靶点;通过VennDiagram软件获得交集靶点(红柳和ALI);根据疾病-活性成分-交集靶点网络数据,最终遴选出主要活性成分和致病的关键靶点进行分子对接.动物实验采用慢性酒精喂养加急性灌胃法建立C57BL/6J小鼠ALI模型.通过丙二醛(MDA)、谷草转氨酶(AST)、谷丙转氨酶(ALT)、肝脏指数、HE染色、NF-κB p65蛋白表达水平等指标验证红柳对ALI的作用机制.结果 通过网络药理学从红柳中筛选获得活性成分12个,与ALI交集靶点共151个.推测红柳的主要活性成分为槲皮素、山柰酚、异鼠李素等,通过RELA/NF-KBp65、JUN、MAPK1、AKT1等关键靶点调节脂质-动脉粥样硬化、糖尿病并发症AGE-RAGE以及流体剪切应力-动脉粥样硬化等信号通路来发挥抗ALI作用.分子对接显示红柳主要活性成分与通路关键靶点蛋白结合能量均≤-28.8696 kJ·mol-1.动物实验结果显示,与模型组相比,红柳组肝脏指数、MDA、ALT、AST和NF-KB p65水平均有所下降,HE染色显示肝组织变性情况减轻.结论 本研究初步揭示了红柳可通过多化学成分、多靶点、多通路对ALI起一定的保护作用,为天然药用植物的开发和利用提供了理论参考.
Effect of Tamarix ramosissima Ledeb on alcoholic liver injury based on network pharmacology and molecular docking technology
Objective To determine the mechanism of the natural plant Tamarix ramosissima Ledeb on alcoholic liver injury(ALI)in mice by network pharmacology and molecular docking technology.Methods The active ingredients were screened,with the oral availability(≥30%)and druglikeness(≥0.18)pre-ordained.ALI related targets were screened by databases like GeneCards and DrugBank.Via VennDiagram,an intersection target(Tamarix ramosissima Ledeb and ALI)was obtained.Based on the disease-active ingredients-intersection target network,the main active ingredients and key pathogenic targets were ultimately selected for molecular docking.Animal experiments were conducted with chronic alcohol feeding and acute gastric lavage to establish the C57BL/6J mouse ALI model.By detecting malondialdehyde(MDA),aspartate transaminase(AST),alanine transaminase(ALT),liver index,HE staining,NF-κB p65,the Tamarix ramosissima Ledeb action mechanism on ALI was validated.Results Through network pharmacology screening,12 active ingredients were obtained,with 151 targets intersecting with ALI.It was speculated that the main active components,included quercetin,kaempferol,and isorhamnetin.Via the key targets(RELA/NF-κB p65,JUN,MAPK1,and AKT1)signal pathways were regulated,like lipid and atheroscierosis,diabetes complications AGE-RAGE,fluid shear stress and atheroscierosis were controled to play the anti-ALI role.The molecular docking showed that the binding energy of the main active components and pathway key target proteins were-28.8696 kJ·mol-1.The experimental research on mice showed the liver index,MDA,ALT,AST and NF-κB p65 levels all decreased in the Tamarix ramosissima Ledeb groups,and the liver tissue degeneration reduced.Conclusion Tamarix ramosissima Ledeb has a certain protective effect on ALI through multiple ingredients,targets,and pathways.

Tamarix ramosissima Ledebalcoholic liver injurynetwork pharmacologymolecular docking technologymechanism

刘晓航、凌修妍、徐睿君、郭昕明、陈婷玉、付金环、范可欣、高祎婷

展开 >

新疆第二医学院药学院,新疆 克拉玛依 834000

红柳 酒精性肝损伤 网络药理学 分子对接技术 作用机制

新疆维吾尔自治区级大学生创新创业训练计划

S202213560018

2024

中南药学
湖南省药学会

中南药学

CSTPCD
影响因子:0.736
ISSN:1672-2981
年,卷(期):2024.22(5)
  • 24